Topic: Lupus
A new vaccine-like therapy that summons a host of antibodies to fight lupus has shown promise in early European trials, researchers said at a US conference on Tuesday.There are very few options for treating the potentially fatal disease in which the body's ...
LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta, in a defeat for rival drugmaker Eli Lilly.The UK Supreme Court ruling chimes with similar ...
NEW YORK (Reuters Health) - Despite a commonly-held belief among many doctors who treat lupus patients, headaches -- particularly migraines -- are not a manifestation of that disease and should be treated as a separate problem, report researchers in Greece.Previous studies that ...
LONDON (Reuters) - Benlysta, the first new treatment for lupus in half a century, was approved for use in Europe, the drug's discoverer Human Genome Sciences and partner GlaxoSmithKline said on Thursday.The drug, which combats lupus -- a disease that causes the ...
LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar" class="inform">dollar sales expectations for its makers.The companies said the European Medicines Agency had ...
LONDON (Reuters) - The first new treatment for lupus in a half-century was recommended for approval in Europe on Friday, offering a new option for patients and underpinning multibillion-dollar" class="inform">dollar sales expectations for its makers.The companies said the European Medicines Agency had ...
US health officials Wednesday announced approval of the first new drug in 56 years to treat lupus, a potentially fatal autoimmune disease affecting millions worldwide.The US Food and Drug Administration said it approved belimumab, marketed under the trade name Benlysta, an inhibitor ...
CHICAGO (Reuters) - Aiden Gallagher started developing symptoms of lupus at age 11 after a spider bite that left her hand swollen for weeks.Gallagher, now 18, took strong doses of the steroid prednisone to help control the disease, in which the immune ...
WASHINGTON (Reuters) - The first new treatment in a half-century for the autoimmune disease lupus won U.S. approval on Wednesday. The drug, Benlysta from Human Genome Sciences Inc, is given once a month by intravenous infusion.Below are some facts about lupus, current ...
WASHINGTON (Reuters) - Human Genome Sciences Inc's lupus drug is poised to win clearance this week, offering patients the first approved treatment option in a half-century and setting the company up for blockbuster sales.Industry analysts widely expect Benlysta, one the most closely ...
